IOVA Files 2024 10-K
Ticker: IOVA · Form: 10-K · Filed: Feb 27, 2025 · CIK: 1425205
| Field | Detail |
|---|---|
| Company | Iovance Biotherapeutics, Inc. (IOVA) |
| Form Type | 10-K |
| Filed Date | Feb 27, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, biotech
TL;DR
IOVA dropped its 2024 10-K. Check financials.
AI Summary
IOVA filed its 2024 10-K on February 27, 2025, detailing its fiscal year ending December 31, 2024. The company, formerly known as Lion Biotechnologies, Inc., is focused on biological products. Its principal executive offices are located at 825 Industrial Road, 4th Floor, San Carlos, CA 94070.
Why It Matters
This filing provides a comprehensive overview of IOVA's financial performance and business operations for the fiscal year 2024, crucial for investors assessing the company's current standing and future prospects.
Risk Assessment
Risk Level: medium — As a biopharmaceutical company, IOVA faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2024 — Fiscal Year End (The period covered by the 10-K filing.)
- 20250227 — Filing Date (The date the 10-K was submitted to the SEC.)
Key Players & Entities
- IOVANCE BIOTHERAPEUTICS, INC. (company) — Filer
- 20241231 (date) — Fiscal year end
- 20250227 (date) — Filing date
- Lion Biotechnologies, Inc. (company) — Former company name
- 825 INDUSTRIAL ROAD, 4TH FLOOR, SAN CARLOS, CA 94070 (location) — Business and mailing address
FAQ
What is the primary business of IOVANCE BIOTHERAPEUTICS, INC.?
IOVANCE BIOTHERAPEUTICS, INC. is primarily involved in biological products, as indicated by its SIC code [2836].
When did IOVANCE BIOTHERAPEUTICS, INC. file its 10-K for the fiscal year 2024?
The 10-K for the fiscal year ending December 31, 2024, was filed on February 27, 2025.
What was IOVANCE BIOTHERAPEUTICS, INC. formerly known as?
IOVANCE BIOTHERAPEUTICS, INC. was formerly known as Lion Biotechnologies, Inc., with a name change effective October 15, 2013.
Where are IOVANCE BIOTHERAPEUTICS, INC.'s principal executive offices located?
The company's business and mailing address is 825 Industrial Road, 4th Floor, San Carlos, CA 94070.
What is the SEC file number for IOVANCE BIOTHERAPEUTICS, INC.?
The SEC file number for IOVANCE BIOTHERAPEUTICS, INC. is 001-36860.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on February 27, 2025 regarding IOVANCE BIOTHERAPEUTICS, INC. (IOVA).